GRAIL, Inc. $GRAL Shares Acquired by American Century Companies Inc.

American Century Companies Inc. lifted its position in shares of GRAIL, Inc. (NASDAQ:GRAL) by 47.6% in the first quarter, HoldingsChannel reports. The institutional investor owned 17,702 shares of the company’s stock after purchasing an additional 5,712 shares during the period. American Century Companies Inc.’s holdings in GRAIL were worth $452,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in GRAL. Sessa Capital IM L.P. acquired a new stake in GRAIL during the fourth quarter worth about $53,550,000. Jacobs Levy Equity Management Inc. acquired a new stake in GRAIL during the fourth quarter worth about $18,209,000. Wealthquest Corp acquired a new stake in GRAIL during the 1st quarter worth approximately $18,247,000. Bank of America Corp DE acquired a new stake in GRAIL during the 4th quarter worth approximately $10,638,000. Finally, Newtyn Management LLC acquired a new stake in GRAIL during the 4th quarter worth approximately $7,140,000.

Insider Activity

In other news, major shareholder Chun R. Ding sold 339,800 shares of the firm’s stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $49.53, for a total transaction of $16,830,294.00. Following the completion of the sale, the insider directly owned 3,305,055 shares in the company, valued at $163,699,374.15. This trade represents a 9.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Aaron Freidin sold 8,000 shares of the firm’s stock in a transaction dated Tuesday, July 15th. The shares were sold at an average price of $38.93, for a total value of $311,440.00. Following the sale, the chief financial officer owned 286,020 shares of the company’s stock, valued at $11,134,758.60. This represents a 2.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 361,694 shares of company stock worth $17,780,266 over the last ninety days. Corporate insiders own 1.85% of the company’s stock.

GRAIL Stock Up 9.9%

Shares of NASDAQ:GRAL opened at $36.91 on Friday. The company has a 50 day moving average of $36.74 and a two-hundred day moving average of $35.80. The company has a market capitalization of $1.33 billion, a price-to-earnings ratio of -2.82 and a beta of 3.18. GRAIL, Inc. has a 52-week low of $12.33 and a 52-week high of $63.99.

GRAIL (NASDAQ:GRAL) last released its quarterly earnings results on Tuesday, August 12th. The company reported ($3.18) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.14) by ($0.04). The firm had revenue of $35.54 million for the quarter, compared to analyst estimates of $37.57 million. GRAIL had a negative net margin of 329.86% and a negative return on equity of 16.64%. On average, equities analysts anticipate that GRAIL, Inc. will post -15.15 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group increased their target price on shares of GRAIL from $32.00 to $43.00 and gave the stock a “buy” rating in a research report on Wednesday, May 14th. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, GRAIL has an average rating of “Hold” and a consensus target price of $31.50.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.